Concepedia

Flonza Isa

FI

Statistics

Publications

9

Citations

737

H-Index

9

Active since

2016

Affiliations

Regeneron (United States)(Current)

University of Washington

Fred Hutch Cancer Center

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Flonza Isa is an author at Regeneron (United States) specializing in infectious diseases, pharmacotherapy, and antiviral therapy.

ORCID

Publications per year

2016–2023

9

Publications

9

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

Meagan P. O’Brien, Eduardo Forleo‐Neto, Bret J. Musser et al. · New England Journal of Medicine · 2021 · 480 citations · Full text

, , +17

Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis

Flonza Isa, Sean Collins, Myung Hee Lee et al. · EBioMedicine · 2018 · 66 citations · Full text

, , +9

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

Dean Follmann, Meagan P. O’Brien, Jonathan Fintzi et al. · Nature Communications · 2023 · 44 citations · Full text

, , +17

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

Gary Herman, Meagan P. O’Brien, Eduardo Forleo‐Neto et al. · The Lancet Infectious Diseases · 2022 · 41 citations · Full text

, , +8

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19

Flonza Isa, Eduardo Forleo‐Neto, Jonathan Meyer et al. · International Journal of Infectious Diseases · 2022 · 32 citations · Full text

, , +13

1–5 of 9